<DOC>
	<DOCNO>NCT00870883</DOCNO>
	<brief_summary>Oxidative stress associate kidney damage several different situation , include hypotension . In animal model show combination n-acetylcysteine plus deferoxamine superior isolate use treatment several disease . Thus investigator aim determine administration n-acetylcysteine plus deferoxamine could prevent renal failure critical ill patient develop hypotension .</brief_summary>
	<brief_title>N-acetylcysteine Plus Deferoxamine Patients With Hypotension</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>Patients admit ICU Presenting hypothesion ( MAP &lt; 60mm Hg needing use vasoactive drug ) least 30 min last 12h study inclusion Age low 18 year old Chronic renal failure A known history allergy study drug Using nacetylcysteine paracetamol overdose Pregnant woman Patients use iodinate contrast medium Hemoglobin le 6.5 mg/dl Cancer patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>